We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Revises Guidance on Classification Of Advanced Therapy Drug Products
EMA Revises Guidance on Classification Of Advanced Therapy Drug Products
The European Medicines Agency’s Committee for Advanced Therapies has clarified when drugs may be classified as advanced therapy medicinal products, including the criteria for classifying cells and tissues as engineered.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor